Diabetology is a specialty biopharmaceutical company employinga proprietary oral delivery system to administerknown bioactives as well as novel compoundsfor the comprehensive management of diabetes.
With key personnel in Research, Clinical Development and Commercial functions, the Company is fully committed to taking its own research into clinical human studies, and beyond.
Diabetology’s philosophy is to form collaborations & partnerships to further key projects, and to outsource many non-core activities. Thus we are able to keep overheads low, conserving shareholders’ resources.
Based in Jersey, Diabetology is a privately owned and funded company with a research and business development centre in London.